
Laurus Labs Hits New 52-Week High of Rs.1046, Marking Strong Momentum
2025-12-19 09:55:52Laurus Labs, a key player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs.1046 today, reflecting sustained momentum and robust market performance over recent sessions.
Read More
Laurus Labs Stock Hits All-Time High Amid Strong Performance
2025-12-19 09:33:10Laurus Labs has reached a new all-time high, touching Rs.1041.2 today, marking a significant milestone in the company’s journey within the Pharmaceuticals & Biotechnology sector. This achievement reflects a sustained period of robust performance and notable returns compared to broader market indices.
Read More
Laurus Labs Technical Momentum Shifts Signal Changing Market Dynamics
2025-12-19 08:11:01Laurus Labs, a key player in the Pharmaceuticals & Biotechnology sector, has exhibited notable shifts in its technical momentum, reflecting evolving market dynamics. Recent assessment changes highlight a transition in price momentum and technical indicators, suggesting a nuanced outlook for investors tracking this mid-cap stock.
Read More
Laurus Labs Sees Revision in Market Evaluation Amid Strong Financials
2025-12-17 10:10:20Laurus Labs, a midcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting recent shifts in its fundamental and technical outlook. Despite this adjustment, the company continues to demonstrate robust financial performance and market resilience.
Read More
Laurus Labs Technical Momentum Shifts Amid Mixed Indicator Signals
2025-12-17 08:14:14Laurus Labs, a key player in the Pharmaceuticals & Biotechnology sector, is exhibiting a nuanced shift in its technical momentum as recent evaluation adjustments reflect a transition from a bullish to a mildly bullish trend. This development comes amid a complex interplay of technical indicators, including MACD, RSI, moving averages, and others, which collectively paint a detailed picture of the stock’s current market stance.
Read More
Laurus Labs Hits New 52-Week High of Rs.1040, Marking Significant Milestone
2025-12-01 11:27:13Laurus Labs, a key player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs.1040 today, underscoring a notable phase of momentum in its stock performance. This milestone reflects the company’s sustained upward trajectory amid a broadly positive market environment.
Read More
Laurus Labs Hits New 52-Week High of Rs.1040 Marking Significant Milestone
2025-12-01 11:27:12Laurus Labs, a key player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high today, touching Rs.1040. This milestone reflects the stock’s sustained momentum and strong performance over the past year, significantly outpacing broader market indices.
Read More
Laurus Labs Hits New 52-Week High of Rs.1040 Marking Significant Milestone
2025-12-01 11:27:09Laurus Labs has reached a new 52-week high, touching Rs.1040 today, underscoring a notable milestone in its market performance within the Pharmaceuticals & Biotechnology sector. This achievement reflects sustained momentum supported by strong financial metrics and positive quarterly results.
Read More
Laurus Labs Hits New 52-Week High of Rs.1040 Marking Strong Market Momentum
2025-12-01 11:27:09Laurus Labs, a prominent player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs.1040 today, underscoring a significant milestone in its market performance. This achievement reflects sustained momentum supported by robust financial metrics and favourable market conditions.
Read MoreAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
12-Dec-2025 | Source : BSEPlease see annexed enclosure
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
02-Dec-2025 | Source : BSEPlease see annexed enclosure
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
19-Nov-2025 | Source : BSEPlease see annexed enclosure
Corporate Actions
No Upcoming Board Meetings
Laurus Labs Ltd has declared 40% dividend, ex-date: 31 Oct 25
Laurus Labs Ltd has announced 2:10 stock split, ex-date: 29 Sep 20
No Bonus history available
No Rights history available






